Company Filing History:
Years Active: 1987
Title: The Innovative Mind of Bernd Aufdembrinke
Introduction
Bernd Aufdembrinke, based in Berlin, Germany, is a prominent inventor known for his significant contributions to the field of geriatrics. He holds a patent that addresses geriatric deficiencies, showcasing his dedication to improving the quality of life for elderly patients.
Latest Patents
Bernd Aufdembrinke's notable patent is titled "Use of Terguride as a Geriatric Agent." This invention outlines the use of Terguride and its physiologically compatible salts for the treatment of various geriatric deficiencies. The recommended dosage range is between 0.1 to 5.0 mg/day, highlighting Aufdembrinke's commitment to precise and effective medical solutions.
Career Highlights
As an integral member of Schering Aktiengesellschaft, Bernd Aufdembrinke has made significant strides in pharmaceutical innovation. His work has not only contributed to the company's portfolio of healthcare solutions but has also advanced the understanding of geriatric care.
Collaborations
Throughout his career, Aufdembrinke has collaborated with esteemed colleagues such as Rainer Dorow and Reinhard Horowski. These partnerships have been crucial in the development and refinement of his patented inventions, ensuring a multidisciplinary approach to innovation.
Conclusion
In summary, Bernd Aufdembrinke represents a dedication to advancing medical science through innovation. His patent for Terguride as a geriatric agent underscores the importance of tailored treatments for aging populations, making a significant impact on the field of geriatrics. His ongoing contributions and collaborations pave the way for future advancements in healthcare.